{"id":584,"date":"2022-09-26T08:58:56","date_gmt":"2022-09-25T23:58:56","guid":{"rendered":"https:\/\/cichlid.tech\/?post_type=contents&#038;p=584"},"modified":"2023-08-31T08:59:22","modified_gmt":"2023-08-30T23:59:22","slug":"deep-bio-to-supply-ai-based-prostate-cancer-diagnosis-sw-to-denmark","status":"publish","type":"contents","link":"https:\/\/cichlid.tech\/en\/contents\/deep-bio-to-supply-ai-based-prostate-cancer-diagnosis-sw-to-denmark\/","title":{"rendered":"Deep Bio to supply AI-based prostate cancer diagnosis SW to Denmark"},"content":{"rendered":"<p>Deep Bio said it signed a partnership with Visiopharm, a Danish pharmaceutical company, to supply DeepDx Prostate, its deep learning-based prostate cancer pathology image analysis software.<\/p>\n<p>Under the agreement, Deep Bio will be able to expand pathologists&#8217; access to advanced AI pathology solutions by linking DeepDx Prostate with Visiopharm&#8217;s &#8220;App Center.&#8221;  The App Center provides a wide range of artificial intelligence (AI) analysis solutions that assist in the diagnosis of various cancers.<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","contents-tax":[10],"acf":[],"_links":{"self":[{"href":"https:\/\/cichlid.tech\/en\/wp-json\/wp\/v2\/contents\/584"}],"collection":[{"href":"https:\/\/cichlid.tech\/en\/wp-json\/wp\/v2\/contents"}],"about":[{"href":"https:\/\/cichlid.tech\/en\/wp-json\/wp\/v2\/types\/contents"}],"wp:attachment":[{"href":"https:\/\/cichlid.tech\/en\/wp-json\/wp\/v2\/media?parent=584"}],"wp:term":[{"taxonomy":"contents-tax","embeddable":true,"href":"https:\/\/cichlid.tech\/en\/wp-json\/wp\/v2\/contents-tax?post=584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}